Skip to main content
Get Started

JOIN POLYMEDCO AT ACEP24

Sept 29-Oct 2 | Las Vegas, NV | Booth #1213

 

See PATHFAST® hs-cTn-II, the first and only high-sensitivity cardiac troponin (hs-cTn) assay cleared for point-of-care (POC) use by the FDA.

Polymedco_Logo_RGB_Color
ADLM

Helping save lives through the early detection of life-threatening diseases

PATHFAST_DSC01150@2x

Live PATHFAST Analyzer demonstration

See PATHFAST in action.

Mahler layout for LP no text

ACEP24 Expert Theater

Integrating point-of-care high-sensitivity troponin into your workflow 

Presented by Dr Simon Mahler

Sun, Sept 29, 2:30 PM PDT 

Bayside BC, Expert Theater 1

The wait is over

PATHFAST hs-cTnl-II at the point of care

Now FDA-cleared

hs-cTn is the preferred assay for the assessment of patients with suspected Acute Myocardial Infarction (AMI)1

Don’t miss the highly anticipated expert theater

What’s next in ED chest pain care: integrating point-of-care hs-cTn into your workflow

Sponsored by Polymedco

Sunday, September 29 | 2:30 PM PDT

Presented by Simon A. Mahler, MD, MS, FACEP

Wake Forest School of Medicine

Discover how PATHFAST hs-cTnI-II, the first and only FDA-cleared POC hs-cTn, supports accelerated diagnostic protocols in patients with chest pain.

Simon_Mahler_Graphic@2x

Ready to accelerate urgent cardiac care decisions in your ED?

What are you waiting for?

Enter your name and email address to receive more information about PATHFAST hs-cTnI-II.
About Polymedco

Polymedco partners with healthcare systems, payors, providers, and reference labs to develop best-in-class screening and early detection programs that can help identify life-threatening diseases earlier. We’re proud to offer a portfolio of products with exceptional performance, robust clinical evidence, and user-friendly design.

Visit us in booth #1213 at ACEP24  to learn more

 

References

  1. Kontos, M, de Lemos, J. et al. 2022 ACC Expert consensus decision pathway on the evaluation and disposition of acute chest pain in the emergency department: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;80(20):1925-1960. doi:10.1016/j.jacc.2022.08.750

 

81166-00